Periodontitis, microbiomes and their role in Alzheimer’s disease by Pritchard, Anna et al.
Article
Periodontitis, microbiomes and their role in 
Alzheimer’s disease
Pritchard, Anna, Crean, Stjohn, Olsen, Ingar and Singhrao, Simarjit 
Kaur
Available at http://clok.uclan.ac.uk/20389/
Pritchard, Anna ORCID: 0000­0002­6280­7008, Crean, Stjohn ORCID: 0000­0001­9336­8549, 
Olsen, Ingar and Singhrao, Simarjit Kaur ORCID: 0000­0001­9573­5963 (2017) Periodontitis, 
microbiomes and their role in Alzheimer’s disease. Frontiers in Aging Neuroscience, 9 (336).  
It is advisable to refer to the publisher’s version if you intend to cite from the work.
http://dx.doi.org/10.3389/fnagi.2017.00336
For more information about UCLan’s research in this area go to 
http://www.uclan.ac.uk/researchgroups/ and search for <name of research Group>.
For information about Research generally at UCLan please go to 
http://www.uclan.ac.uk/research/ 
All outputs in CLoK are protected by Intellectual Property Rights law, including
Copyright law.  Copyright, IPR and Moral Rights for the works on this site are retained 
by the individual authors and/or other copyright owners. Terms and conditions for use 
of this material are defined in the http://clok.uclan.ac.uk/policies/
CLoK
Central Lancashire online Knowledge
www.clok.uclan.ac.uk
REVIEW
published: 24 October 2017
doi: 10.3389/fnagi.2017.00336
Periodontitis, Microbiomes and their
Role in Alzheimer’s Disease
Anna B. Pritchard1, StJohn Crean1, Ingar Olsen2 and Sim K. Singhrao1*
1Dementia & Neurodegenerative Diseases Research Group, Faculty of Clinical and Biomedical Sciences, School of Dentistry,
University of Central Lancashire, Preston, United Kingdom, 2Department of Oral Biology, Faculty of Dentistry, University of
Oslo, Oslo, Norway
Edited by:
Changiz Geula,
Northwestern University,
United States
Reviewed by:
Shelley J. Allen,
University of Bristol, United Kingdom
Marcus O. Grimm,
Saarland University, Germany
*Correspondence:
Sim K. Singhrao
sksinghrao@uclan.ac.uk
Received: 10 July 2017
Accepted: 02 October 2017
Published: 24 October 2017
Citation:
Pritchard AB, Crean S, Olsen I and
Singhrao SK (2017) Periodontitis,
Microbiomes and their Role in
Alzheimer’s Disease.
Front. Aging Neurosci. 9:336.
doi: 10.3389/fnagi.2017.00336
As far back as the eighteenth and early nineteenth centuries, microbial infections were
responsible for vast numbers of deaths. The trend reversed with the introduction of
antibiotics coinciding with longer life. Increased life expectancy however, accompanied
the emergence of age related chronic inflammatory states including the sporadic form
of Alzheimer’s disease (AD). Taken together, the true challenge of retaining health into
later years of life now appears to lie in delaying and/or preventing the progression
of chronic inflammatory diseases, through identifying and influencing modifiable risk
factors. Diverse pathogens, including periodontal bacteria have been associated with
AD brains. Amyloid-beta (Aβ) hallmark protein of AD may be a consequence of infection,
called upon due to its antimicrobial properties. Up to this moment in time, a lack of
understanding and knowledge of a microbiome associated with AD brain has ensured
that the role pathogens may play in this neurodegenerative disease remains unresolved.
The oral microbiome embraces a range of diverse bacterial phylotypes, which especially
in vulnerable individuals, will excite and perpetuate a range of inflammatory conditions,
to a wide range of extra-oral body tissues and organs specific to their developing
pathophysiology, including the brain. This offers the tantalizing opportunity that by
controlling the oral-specific microbiome; clinicians may treat or prevent a range of
chronic inflammatory diseases orally. Evolution has equipped the human host to combat
infection/disease by providing an immune system, but Porphyromonas gingivalis and
selective spirochetes, have developed immune avoidance strategies threatening the
host-microbe homeostasis. It is clear from longitudinal monitoring of patients that
chronic periodontitis contributes to declining cognition. The aim here is to discuss the
contribution from opportunistic pathogens of the periodontal microbiome, and highlight
the challenges, the host faces, when dealing with unresolvable oral infections that may
lead to clinical manifestations that are characteristic for AD.
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INTRODUCTION
Alzheimer’s disease (AD) is the most common example of dementia causing around 60%–80%
of all cases (Gaugler et al., 2016). AD is characterized by cognitive deficit and has a complex,
multifactorial etiology. The limited treatment options make it a challenging condition in which
neuropsychiatrists/neurologists can do little to help their patients. The relentlessly downward
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course of the disease has impact on both the patient and
their carers. Furthermore, the rising aging population and the
predicted increase in the prevalence of the disease has immediate
and long-term socioeconomic implications (Prince et al., 2014).
Classically there are two forms of this neurodegenerative
condition. The familial/early-onset form displaying an earlier
manifestation, albeit in fewer (<5%) AD cases is overall,
more severe with increased functional loss and Aβ deposits
(Bekris et al., 2010). Susceptibility genes and their co-expressing
environmental factors appear to exert influence over the
sporadic/late-onset form, which accounts for the majority
(95%) of AD cases. AD has a bi-phasic criterion of diagnosis,
which involves correlation of the clinical presentation with
neuropathological examination, at post-mortem (Braak and
Braak, 1995). Despite the difference between familial and
sporadic AD, the underlying neuropathology remains common
to both forms.
The two diagnostic neuropathological hallmarks are
numerous extracellular deposits of amyloid-beta (Aβ plaques)
and neurofibrillary tangles (NFTs) in the frontal cortex and
the hippocampal areas of the brain (Braak and Braak, 1995).
In the brain, Aβ can take different physiological states (soluble
monomers, dimers, insoluble Aβ40/42), which eventually result
in an insoluble, stable β-helical sheet structure in the form
of two morphologically different plaques. The senile plaques
are composed of densely packed Aβ1–42, and known for their
cytotoxicity in causing demise of surrounding neurons (McGeer
et al., 2017). The NFTs, located within cortical neurons, are
composed of paired helical filaments (PHFs) and tau protein, the
latter of which undergoes posttranslational modification in the
form of hyperphosphorylation.
In addition to the classic diagnostic hallmark proteins,
is the apparently asymptomatic developing neuropathology.
Biomarker studies using positron emission tomography for levels
of Aβ, and magnetic resonance imaging for brain volume,
indicate that AD onset begins years before the clinical picture
emerges (McGeer et al., 2017). Cerebral inflammation in the
form of activated glia (microglia and astrocytes; Norden and
Godbout, 2013), and Aβ1–40 plaques are two of the many
asymptomatic features seen in AD. This implies that age-related
priming of glia due to bacterial entry from hosts’ dysbiotic
microbiomes elsewhere in the body (oral, gastrointestinal (GI)
tract) provide slow inflammatory damage. In support, oral
pathogens, especially Porphyromonas gingivalis, thrive under
toxic inflammatory conditions and if present, may dampen the
early pathogenic effects of glial cell activation (Singhrao et al.,
2015). This makes the findings of a recent retrospective cohort
study highlighting a 10-year exposure to chronic periodontitis
may lead to manifesting AD (Chen et al., 2017), very plausible.
Whether inflammation precedes Aβ or vice versa, is not clear;
but considering Aβ as an innate immune protein with its
antimicrobial properties (Soscia et al., 2010; Kumar et al., 2016)
would place infections upstream of this hallmark protein. A
suggested sequence of AD pathophysiology would likely follow
infections, Aβ deposition and glial cell activation. These three
events may also provide an explanation for the age related glial
cell priming by genetic switches turning on, during life, in an age
dependentmanner (Jayadev et al., 2013; Fan et al., 2017;Wu et al.,
2017).
If atrophy of soft and bony tissues classically refers to
decreased cell size/cell loss, such an observation can equally,
imply shrinkage as a marker post inflammation. Brain atrophy
is also a feature of multiple sclerosis (Pérez-Cerdá et al., 2016),
which potentially presents with similar immune (innate and
adaptive) tissue response as that seen in periodontal disease
(Di Benedetto et al., 2013; Olsen et al., 2016). In periodontitis,
the localized bacterial accumulation results in stimulations that
elicit inflammation and activation of the innate immune system.
Influx of systemic inflammatory cells follows a short time
afterwards by an adaptive immune cell response leading to
tissue loss (Di Benedetto et al., 2013; Olsen and Singhrao, 2015;
Olsen et al., 2016). Recent evidence suggests that the adaptive
immune system may have an important role in suppressing
AD neuropathology (Marsh et al., 2016; Olsen et al., 2016).
It may therefore be that, with aging and a waning adaptive
immune system, AD neuropathology may be more likely to
be evident. Additional to this, both periodontal pathogens
(P. gingivalis and Treponema denticola) show weak responses for
attracting systemic inflammatory cells (neutrophils, T/B cells)
into the brain (Olsen et al., 2016). However, the concept of
inflammation and macroscopic atrophic appearance (enlarged
sulci and ventricles) unique to AD brains may offer similar clues
for a pivotal and primary role of inflammation (Figure 1) at the
organ level.
The atrophic appearance of AD brains corroborates
inflammation and is a compelling indication of numerous
bacteria/bacterial endo/exo/toxins and fungi/viruses observed
in association with Aβ plaques (Hill et al., 2014; Itzhaki, 2016;
Lukiw, 2016; Pistollato et al., 2016; Alonso et al., 2017; Harris
and Harris, 2017; Jiang et al., 2017; Maheshwari and Eslick, 2017;
Zhao et al., 2017). The large microbial biodiversity identified
from post-mortem AD brain specimens could be because of
the differences in age, diet, lifestyle, geographical environment
and disease status, a limitation also recognized by the human
microbiome project1. This places a greater onus on microbial
virulence factor(s)/pathogen associated molecular patterns
(PAMPs) than live microbes exerting a pathological effect with
the common end-point of this neurodegenerative disease. An
example of this is the detection of lipopolysaccharide (LPS) in
AD brains with the resulting opsonization of LPS-producing
bacteria by glial cells (Poole et al., 2013), and their direct
binding with Aβ plaques (Zhan et al., 2016; Zhao et al., 2017).
Undoubtedly, LPS from the outer membrane of Gram-negative
bacteria is a powerful pro-inflammatory PAMP. This may carry
with it proteolytic enzymes (gingipains, peptidyl deiminases
and carbonic anhydrases) and appendages such as fimbriae
and curli fibers (curli are functional amyloids housed on the
outer membrane of several prokaryotes) and other amyloid-like
proteins (Table 1). In vivo experimental models have suggested
LPS from oral, Gram negative bacteria having a role in
chronic local inflammation (DiCarlo et al., 2001); Aβ release
(Sheng et al., 2003; Wu et al., 2017); worsened cognition
1http://www.hmpdacc.org/
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FIGURE 1 | Schematic illustrating the macroscopic features relating to shrinkage (wider sulci, compared with non-Alzheimer’s disease (AD) brain), unique to the AD
brain, which equates to inflammatory condition. The pathogens disrupt the epithelial cell-to-cell proteins of the gingivae through their proteases. The
epithelial/endothelial barriers of capillaries disrupted for effective bacteremia to take place. The olfactory nerve pathways exploited to evade immune recognition.
Environmental factors are the inflammophilic microbes with potential to subvert hosts immune defenses that also contribute to common inflammatory
activities/pathways (p’ways) as well as contributing to proteostasis. At this stage the brain’s resilience is markedly compromised and the blood-brain barrier (BBB) is
becoming defective. The endotoxin intolerance/further inflammation tip the brain into disease.
TABLE 1 | Prokaryotes and eukaryotes found in biofilm communities with genes for expressing functional amyloids.
Species/Genera/Phylotypes Protein Protein function References
Pseudomonas FapC Biofilm formation, virulence factor Larsen et al. (2007) and Dueholm et al. (2010)
Escherichia coli CsgA, Curli Biofilm formation, virulence factor Chapman et al. (2002), Dueholm et al. (2012) and
Zhan et al. (2016)
Klebsiella pneumoniae Microcin E492 Cytotoxicity Bieler et al. (2005)
Mycobacterium tuberculosis MTP Adhesive pili Alteri et al. (2007)
Bacillus subtilis TasA Biofilm Romero et al. (2010, 2011, 2014)
Salmonella enterica Curli Biofilm, virulence factor Solomon et al. (2005)
Salmonella typhimurium Curli Biofilm, virulence factor Castelijn et al. (2012)
Streptococcus mutans Adhesin P1 Biofilm, caries Oli et al. (2012)
Bacteroidetes Curli Biofilm Larsen et al. (2008) and Dueholm et al. (2012)
Chloroflexi Curli Biofilm Larsen et al. (2008) and Dueholm et al. (2012)
Firmicutes Curli Biofilm Dueholm et al. (2012)
Thermodesulfobacteria Curli Biofilm Dueholm et al. (2012)
Alpha, beta, delta and gamma-proteoabacteria Curli Biofilm Larsen et al. (2007, 2008), Dueholm et al. (2012,
2013),
Candida albicans Als Adhesion Ramsook et al. (2010) and Garcia et al. (2013)
(Wu et al., 2017); and tau protein phosphorylation (Lee et al.,
2010). More pathogenic bacteria from the GI tract microbiome
appear with curli fibers than presently known for the oral
microbiome and therefore show direct associations with plaques
(Lukiw, 2016; Pistollato et al., 2016; Zhan et al., 2016; Jiang
et al., 2017; Zhao et al., 2017). A recent systematic review in
which meta-analysis of periodontitis with AD was conducted,
demonstrated a significant association between these two
diseases (Odds Ratio (OR) 1.69, 95% CI 1.21–2.35) and an even
more significant association was observed in severe form of
PD with AD (OR 2.98, 95% CI 1.58–5.62; Leira et al., 2017).
A population based retrospective study by Chen et al. (2017)
demonstrated a 10 year, exposure of chronic periodontitis
led to a higher risk (1.707-fold increase) of developing AD.
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Our aim here is to understand how the oral microbiome
pathogens contribute to the hallmark proteins especially
Aβ of AD.
THE ORAL MICROBIOME AND
PERIODONTITIS
Periodontal disease is one of the most common chronic
polymicrobial infections in humans, characterized by loss of
tooth supporting tissues due to the host’s immuno-inflammatory
responses, and consequently are a major cause of loss of teeth.
Loss of more than 16 teeth in early to mid-life is significantly
associated with the development of dementia with OR of
1.56 (95% CI 1.12–2.18; Gatz et al., 2006; Luo et al., 2015).
Conversely, retaining teeth and not brushing them, also exposes
individuals to the risk of developing dementia. Taken together,
the plausible explanation for missing and unclean teeth is poor
oral hygiene (Paganini-Hill et al., 2012). Periodontitis is prevalent
in individuals with poor oral hygiene and high dental plaque
index.
The oral cavity is a home to over 700 different taxa and
undoubtedly, this specific microbiome2 will keep growing, as
changing bacterial species are included. At present, much smaller
numbers 1 × 109/pocket of mixed bacterial phyla (Loesche
and Lopatin, 1998) are associated with periodontitis within this
subgingival niche compared to the oral cavity where 1 × 1011
bacteria/mg of dental plaque are recorded (Li et al., 2000). Dental
plaque is a biofilm of a synergistic microbial community, and
both genetic and environmental factors can cause it to become
dysbiotic and lead to clinical manifestations of periodontitis.
Some common examples of bacteria in the periodontal
microbiome include P. gingivalis, Tannerella forsythia, Prevotella
intermedia, Eikenella corrodens, Fusobacterium nucleatum,
Aggregatibacter actinomycetemcomitans and T. denticola2. The
Gram-negative bacterium P. gingivalis, is a keystone pathogen
that modulates the dysbiosis of its companion species of bacteria
beneath the gingivae (Hajishengallis and Lamont, 2014). The
dysbiotic microbial community model of periodontal disease
explains how a wide range and changing phyla can participate
in generating pathology under the influence of this keystone
pathogen (Hajishengallis and Lamont, 2016). The chronicity of
periodontal disease, resulting in a potentially prolonged assault
by a group of pathogens on the host’s system, opens up the
opportunity of specific microbes inducing a state where the host’s
threshold for disease exceeds that of health allowing local and
remote organ pathology to develop.
ORAL MICROBIOMES CONTRIBUTION
TO AD
Previous reports have alluded to the existence of an unexplored
microbiome in the elderly and AD brains (Riviere et al., 2002),
but the age at which infection takes hold in the brain is unknown.
Microbiomes play an important role in balancing health and
2www.homd.org
disease boundaries. Microbes (oral and non-oral) are implicated
in the etiology of AD; this includes Borrelia species, T. denticola,
P. gingivalis and Escherichia coli (Miklossy, 2011; Poole et al.,
2013; Zhan et al., 2016), oral fungi (Carrasco et al., 2017) and
others (Olsen and Singhrao, 2015; Maheshwari and Eslick, 2017).
The diversity of microbes documented could be a reflection of the
brain donor’s geographical location, their age, diet, oral function
(denture wearing) and lifestyle (Yatsunenko et al., 2012; Lukiw,
2013; Danborg et al., 2014; Heintz and Mair, 2014). Several
scientists including us believe that the AD brain harbors its
own microbiome (Emery et al., 2017), which may be due to
the contribution of ‘‘radicalized’’ bacteria (Harding et al., 2017)
from other human microbiomes (mouth, skin, GI tract), and as a
consequence of the food chain and co-morbid states (Singhrao
et al., 2016). Since age is the major risk factor for developing
AD, then evolving microbiomes may provide dynamics of the
microbial communities over time. To this end, Brandscheid
et al. (2017) examined changes in microbial communities in
the GI tract of the 5XFAD AD transgenic mouse model and
confirmed changes to microbial communities occurred over
time. The changing microbes correlated with changes in trypsin
secretions (Brandscheid et al., 2017), implying meat rich diets are
indigestible in old age and excess protein may upset the existing
microbial community dynamics. If two main phyla of GI tract
bacteria are Firmicutes (approximately 80%) and Bacteroidetes
(approximately 20%; Lukiw, 2016); it appears that during aging
humans also undergo shifts in favor of Bacteroidetes in their GI
tract microbiome (Pistollato et al., 2016). P. gingivalis is a species
within the genus Bacteroides (within the phylum Bacteroidetes)
and with periodontitis becoming more chronic and prevalent in
old age, this would imply that the periodontal microbiome offers
a relatively early indication of changing microbial dynamics.
An AD-specific microbiome might be composed of bacteria
from associated dysbiotic microbiomes because microbial
infections explain the common inflammatory pathways (Olsen
and Singhrao, 2015; Lukiw, 2016; Olsen et al., 2016) and
their effects in the elderly brain via host’s peripheral immune
responses and related signaling pathways (see ‘‘LPS in AD
Inflammatory Cascades’’ section). Undoubtedly, a complex
etiology underlies the clinical manifestations seen in AD
giving rise to new concepts. It is time to re-examine the
infection model that asks: are microbes the causative agents
of AD? This pertinent question anxiously awaits answers
(Fischer, 1910; MacDonald and Miranda, 1987; Miklossy, 1993;
Mawanda and Wallace, 2013; Olsen and Singhrao, 2015; Itzhaki
et al., 2016). To this end, the biofilm concept of AD senile
plaques is proposed (Allen et al., 2016; Miklossy, 2016) and
offers an alternative platform for answering this fundamental
question.
FUNCTIONAL AMYLOIDS FROM
PROKARYOTIC ORIGINS
The prokaryotic functional amyloid (Epstein and Chapman,
2008; Dueholm et al., 2013), affords diverse functions in biofilm
communities that range from structural components namely,
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fimbriae, curli and other cellular appendages to act as oligomeric
toxins (Larsen et al., 2007; Dueholm et al., 2013); reservoirs
for quorum sensing; signaling molecules and binding of redox
mediators (Dueholm and Nielsen, 2017). Furthermore, there is
potential for these prokaryotic Aβ-like fibers to cross the blood-
brain barrier (BBB) and form pathological senile plaques seen
in AD. Presence of curli protein is emphasized by the GI tract
bacteria (Pistollato et al., 2016; Jiang et al., 2017; Zhao et al.,
2017) and as an analogy to prion plaques, help to explain the
protein-protein interactions leading to senile plaque formation
connecting the biofilm hypothesis (Allen et al., 2016; Miklossy,
2016).
Shahnawaz and Soto (2012), reported that the functional
amyloid MccE492 from Klebsiella pneumoniae RYC492 has
the ability to depolymerize from its fibrillary state and
release oligomers capable of inducing cytotoxicity equivalent to
pathological Aβ in AD. This paved the way for the molecular
mimicry theory (Hartman et al., 2013; Friedland, 2015). The
molecular mimicry theory incorporates microbial curli fibers and
human Aβ as a protein-protein interaction, which can result in
cross-seeding even if these proteins are dissimilar (Friedland,
2015). Additional prokaryotic and yeast functional amyloid
systems and their sources are listed in Table 1 (Bian et al., 2000;
Gophna et al., 2001; Larsen et al., 2007, 2008; Dueholm et al.,
2010, 2012, 2013; Dueholm and Nielsen, 2017).
Infections induce acute phase proteins as part of the innate
immune response (Gabay and Kushner, 1999). One of these
is serum amyloid component P (SAP). SAP can bind Candida
albicans (Klotz et al., 2016) in the similar way Aβ binds to
bacteria in its antimicrobial peptide capacity (Soscia et al., 2010;
Kumar et al., 2016). This implies that amyloid-like proteins
(Table 1) from foreign and host sources undergo physical
protein-protein interactions with potential to cross-seed with
Aβ, and increase the amyloid burden. These extrinsic proteins
(curli) are PAMPs (Bian et al., 2000) with β-pleated sheet
structures (Friedland, 2015), and they cross-react with antibodies
to human Aβ plaques (Miklossy, 2016). Due to their density
and morphological appearance, the senile plaques may be
composed of curli-like Aβ1–42 compositions. Would it then
be plausible to suggest that either AD is a result of mixed
pathologies or it has multiple etiological agents (Figure 1)
that bypass protective host barriers, whereby some give rise
to Aβ1–40 and others like curli fibers, cross-seed to generate
Aβ1–42? The molecular mimicry/Aβ cross-seeding hypothesis for
bacterial phylotypes (Hartman et al., 2013; Friedland, 2015) is
attractive as it gives microbes a more prominent role in AD
causality.
SENILE PLAQUE, A MINIATURE BIOFILM
HYPOTHESIS
The proposal that pathogenic microbes (including oral
spirochetes) are able to manifest the pathological and biological
hallmarks of AD led Allen et al. (2016) and Miklossy (2016)
to propose that ‘‘the senile plaques’’ in syphilitic and Lyme
disease brain specimens are conglomerates of pathogenic
bacteria, and can be viewed as multispecies biofilms. This
compelling notion supports the cross-reactivity of antibodies
that detect the breakdown product of the amyloid precursor
protein (APP) Aβ in human AD brains, with the ‘‘Aβ-like’’
senile plaques formed by spirochaetal aggregates in vitro
(Miklossy, 2016). In support of the Allen and Miklossy
biofilm hypothesis, Friedland (2015) proposes a mechanism
in which curli fibers and/or other similar bacterial antigens,
with capacity to aggregate and acquire Aβ conformation
would eventually grow by incorporating host Aβ and
aggregate in the form of AD senile plaques (Friedland,
2015).
Hundreds of synergistic species of bacteria reside within
the organ specific (mouth, skin, GI tract) biofilm ecologies
that outnumber the entire cells making up the human body3.
Given the diversity of microbes identified from AD brains,
it is plausible to expect a heterogeneous biofilm in which
bacteria, fungi and viruses, all reside side by side. Since it is
established that Aβ is an antimicrobial peptide (Soscia et al.,
2010), an expected consequence to microbes would be that of
death, specifically in the context of AD. This together with
the already highly inflamed environment of the AD brain and
ongoing glial cell activity is likely to kill bacteria and exclude
brain abscesses forming. Therefore, the senile plaques of AD
are only likely to retain bacterial virulence factors such as
LPS and genomic DNA signatures. Some bacteria and fungi
form spores within the AD brain tissue and that way, they
bypass the antimicrobial effects of the Aβ40/42. Microbiological
culture based methodologies allow their detection as previously
reported (Balin et al., 2008; Miklossy et al., 2017). This is a
testimony to live microbes having entered the AD brain at
some stage rather than mere contamination of tissue at post-
mortem. C. albicans has also been observed in post mortem
AD brain specimens (Carrasco et al., 2017) and has functional
amyloid-like adhesins (Als) on its cell surface (Ramsook et al.,
2010; Garcia et al., 2013). C. albicans is an opportunistic
yeast found commonly in the oral cavity, where it typically
becomes pathogenic in immunosuppressed individuals or if
local factors are conducive to its growth. For example, if the
individual uses a steroid inhaler or wears dentures (Scully and
Felix, 2005). C. albicans infection can be asymptomatic and
is difficult to eradicate. The concept of trapping/incapacitating
and killing bacteria in the brain by Aβ antimicrobial activity
(Soscia et al., 2010; Kumar et al., 2016) perhaps equally
applies to SAP mediated trapping of C. albicans systemically
(Klotz et al., 2016). However, this affinity could also be due
to the amyloid-like adhesion on the surface of C. albicans
(Ramsook et al., 2010; Garcia et al., 2013). If the senile
plaques represent foci of miniature biofilms, then C. albicans
may be responsible for adding to the Aβ burden by bringing
its own Als (Ramsook et al., 2010; Garcia et al., 2013) and
the insoluble SAP from its primary niche (Ramsook et al.,
2010; Klotz et al., 2016). As human brain Aβ and bacterial
LPS are resistant to degradation, their accumulation is to be
expected.
3http://www.hmpdacc.org/
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LPS in AD Proteostasis
The predominant signaling cascades participating in the innate
immune system in AD pathogenesis include the Toll-like
receptor (TLR) pathways. LPS in rodents demonstrate
participation of TLRs, CD14 and NF-κB signaling cascades
(Olsen and Singhrao, 2015; Lukiw, 2016) and indicates that
acute phase inflammation is beneficial whilst chronic organ
specific inflammation is detrimental (DiCarlo et al., 2001;
Sheng et al., 2003; Lee et al., 2010; Herber-Jonat et al., 2011)
E. coli is a member of the oral microbiome4. genetically
encoded for curli protein, and is included here because of
Friedland’s protein-protein interaction hypothesis for its
plausible contribution to AD senile plaques (Friedland, 2015).
E. coli LPS (presumably with curli), also co-localizes with
AD senile plaques (Zhan et al., 2016; Zhao et al., 2017).
In addition, experiments with peripheral inoculations
of LPS from E. coli in APPswe transgenic mice (Sheng
et al., 2003) have demonstrated increased expression of
APP with Aβ release (Sheng et al., 2003). This result
supports the concept of peripheral inflammation as an
initiating factor in intracerebral inflammatory activity as
well as supporting the release of at least one hallmark
(Aβ) protein (Sheng et al., 2003). More recently, Wu et al.
(2017) demonstrated that repeat injections of LPS from
P. gingivalis, activated cathepsin B (a form of β secretase)
indirectly to cleave APP intracellular fragmentation in an
age-dependent manner. Cathepsin B plays a pivotal role
in the neuroinflammation induced by P. gingivalis LPS
followed by intracellular APP cleavage (Wu et al., 2017).
Functional testing revealed that chronic and systemic
administration of P. gingivalis LPS in middle-aged mice
caused learning and memory deficits (Wu et al., 2017),
supporting an AD-like phenotype and giving this PAMP, from
an oral keystone pathogen, a more prominent role in AD
causality.
Salmonella species enter the oral cavity through consumption
of contaminated meat and eggs (Edwards and Bruner, 1938).
The importance of S. abortus equii (Edwards and Bruner, 1938)
lies in its LPS in relation to neuroinflammation and more
uniquely in tau protein phosphorylation. S. abortus equii LPS
inoculations in the hippocampus of rTg4510 mice carrying
the parental tau mutations and non-transgenic littermates
(Lee et al., 2010), supported an initial neuroinflammatory
activity, followed by increased Ser199/202 and phospho-tau
Ser396 in the mutated group (Lee et al., 2010). This result
demonstrates the role of several bacteria (host microbiome-
derived and extrinsic, food chain sources) and hosts’ genetic
susceptibility contributing to inflammatory stimuli subsequent
to which tau phosphorylation (Lee et al., 2010) takes place.
In other words, the signaling pathways participating in
innate immune mediator release have the potential to
modify the PHF bound tau protein by posttranslational
means, in the vulnerable host, at any time. Thus, NFT
formation could be both dependent and independent of Aβ
deposits.
4www.homd.org
With relevance to AD pathology, a defective BBB is
documented (Montagne et al., 2015; Halliday et al., 2016)
and a plausible explanation for the permeability is related
to loss of cell-cell tight junctional proteins. LPS from some
bacteria such as P. gingivalis also contains proteolytic enzymes
(gingipains) that cleave and fragment proteins into smaller
peptides. The proteolytic activity of gingipains also targets
cell-cell adhesion molecules (Katz et al., 2000; Hintermann
et al., 2002; Sheets et al., 2005). It is, therefore, likely that
gingipains also contribute to the degradation of endothelial
cell tight junction proteins, and contribute to loss of BBB
functional integrity. In support of this hypothesis, P. gingivalis
infected animal models demonstrated hippocampal damage
via inflammation-mediated injury and IgG and gingipains
in the cerebral microvasculature (Singhrao et al., 2017).
In addition, the phagocytic oxidative burst of the host’s
neutrophils and macrophages at a much earlier time point
of P. gingivalis infection, and the oxidative stress response
initiated by bacteria can equally damage the hippocampal
microvasculature (Rokad et al., 2017). A permeable BBB also
has implications for entry of extra-cerebral amyloid/amyloid-
like proteins to the brain and add to the existing amyloid
burden. Furthermore, under appropriate conditions, arginine
residues on the end of fragmented proteins can undergo
citrullination, a form of posttranslational modification, initiated
by P. gingivalis peptidyl arginine deiminase (Bielecka et al.,
2014). This is particularly relevant for retaining C5a activity
and attracting immune cells to the brain (Farkas et al.,
2003; Bielecka et al., 2014). This may be why AD pathology
lacks presence of systemic phagocytes and T/B cells in AD
brains. The insoluble Aβ40/42 however does associate with
macromolecules such as DNA, LPS, metal ions and other
binding proteins (Mueller-Steiner et al., 2006; Itzhaki, 2016;
Maher et al., 2016; Zhan et al., 2016). An explanation for their
binding to Aβ could be to stabilize β-helical sheet structure
formation.
LPS in AD Inflammatory Cascades
The prokaryotic functional amyloids and proteolytic enzymes
have the ability to modulate and induce host responses,
potentially playing a significant role in AD pathogenesis.
For example, P. gingivalis gingipains also affect cellular
functions related to immune signaling. The role of P. gingivalis
negating the adaptive immune system relates to suppression
of interleukin (IL-2) cytokine secretion (Olsen et al., 2016).
The lack of IL-2 enhances innate and humoral immune
responses resulting in a different cytokine profile. This changes
the T helper 17 (Th17) cell lineage, in the modulation
of the Th17/T-regulatory cell (Treg) clone formation. The
result is an imbalance in Th17 and Treg populations as
discussed elsewhere (Olsen et al., 2016). The predominant
signaling cascades participating in the innate immune system
in AD pathogenesis as mentioned earlier include CD14, TLRs
and the NF-κB pathways (Lukiw, 2016), the cAMP-signaling
pathway, the transformation growth factor-beta signaling
pathway (TGF-β) and the p38 mitogen-activated protein kinase
signaling (p38 MAPK) pathway. The latter signaling cascade
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mediates inflammatory and stress responses and is critical
in regulating levels of multiple pro-inflammatory cytokines,
such as tumor necrosis factor-α (TNF-α), IL-1, IL-6 and
IL-8, as well as enzymes involved in inflammatory cascades
e.g., cyclooxygenase and inducible nitric oxide synthase (Chen
et al., 1999; Underwood et al., 2000; Huang et al., 2004). TNF-
α cytokine is significantly upregulated in AD (Tarkowski et al.,
1999), which could be the result of host’s intrinsic genetic
factors such as presenilin 2 and APOE4 allele inheritance
(Jayadev et al., 2013; Fan et al., 2017), whilst co-morbidities
from periodontitis and its etiological polymicrobial pathogens
are also responsible for contributing to this cytokine pool
(Kamer et al., 2009). A consequence of high levels of TNF-α
is that, together with its converting enzyme, this cytokine
can provide positive feedback between the γ-secretase site
fragmentations of the APP into amyloid-alpha (Aα; Allen,
2017). Infections also induce oxidative stress and this too can
have an impact on Aα and Aβ levels through the γ- and
β-secretase cleavage of APP (Tamagno et al., 2008). Some
GI tract microbiome bacteria can alter γ-aminobutyric acid
neurotransmitter signaling by metabolizing glutamate and this
has direct implications for impaired cognition as described by
Pistollato et al. (2016).
FUTURE PERSPECTIVES
From periodontal microbiome perspectives, and rightly so,
much research has focused on making periodontitis an
accepted modifiable risk factor, for AD. The near future
should recapitulate the AD hallmark protein formation
with periodontal polymicrobial oral infections in AD
transgenic models. The foreign amyloid-like proteins
should be isolated and tested for their true potential to
contribute to inflammation and protein-protein interactions
leading to senile plaques in AD. The results will open up
tantalizing modifiable therapies whereby clinicians may
treat or prevent a range of chronic inflammatory diseases
orally through dental intervention, diet (probiotics) and
education.
CONCLUSION
Undoubtedly, a complex etiology underlies the clinical
manifestations seen in AD. Candidate microbes conforming
to the AD microbiome would be those that induce
immunosuppression, are pathogenic, are able to evade
the innate and adaptive immune recognition, incite local
inflammation and are incapable of allowing entry of activated
peripheral blood myeloid cells in the brain. The periodontal
microbiome does concur with the type of expected bacteria
in AD brains. As an analogy to the dysbiotic periodontal
microbial communities driving periodontal disease, the AD
microbiome may reflect similar traits. One such example is
the keystone periodontal pathogen P. gingivalis, which is a
master immune evader and an immunosuppressor of the
host through IL-2 suppression. Although P. gingivalis lacks
the curli gene, it has alternative inflammatory mechanisms
to indirectly activate β secretases and contribute to host
derived Aβ as well as correlate with loss of mental function. A
recent systematic review and a 16-year follow-up retrospective
cohort study significantly link 10-year exposure to chronic
periodontitis as a risk factor for AD. These reports, together
with effort from other researchers firmly places periodontitis
as a risk factor for AD. Alzheimer’s Research UK charity,
suggests that one third of all AD cases are preventable by
reducing modifiable risk factors. This is equivalent to at least
198,000 people in the UK unnecessarily suffering from an
untreatable, mental illness. With periodontitis and AD showing
significant associations, preventative measures must include
dental care as an intervention for all members of the society from
an early age.
AUTHOR CONTRIBUTIONS
ABP initiated the review and wrote most of it. SKS and IO
reviewed and corrected the finer details as PhD supervisors of
ABP. SC provided critical feedback and funding.
FUNDING
This work was supported by the European Commission (FP7-
HEALTH-306029 ‘‘TRIGGER’’) (IO) and the University of
Central Lancashire, UK (SKS, ABP).
ACKNOWLEDGMENTS
IO thanks the European Commission, SKS and ABP the
University of Central Lancashire, UK.
REFERENCES
Allen, H. B. (2017). ‘‘Alzheimer’s disease: assessing the role of
spirochetes, biofilms, the immune system, and amyloid-β with regard
to potential treatment and prevention,’’ in Handbook of Infection
and Alzheimer’s Disease, ed. J. Miklossy (Amsterdam: IOS Press),
83–88.
Allen, H. B., Morales, D., Jones, K., and Joshi, S. (2016). Alzheimer’s
disease: a novel hypothesis integrating spirochetes, biofilm, and the
immune system. J. Neuroinfect. Dis. 7:200. doi: 10.4172/2314-7326.10
00200
Alonso, R., Pisa, D., Aguado, B., and Carrasco, L. (2017). Identification of fungal
species in brain tissue fromAlzheimer’s disease by next-generation sequencing.
J. Alzheimers Dis. 58, 55–67. doi: 10.3233/JAD-170058
Alteri, C. J., Xicohténcatl-Cortes, J., Hess, S., Caballero-Olín, G., Girón, J. A.,
and Friedman, R. L. (2007). Mycobacterium tuberculosis produces pili
during human infection. Proc. Natl. Acad. Sci. U S A 104, 5145–5150.
doi: 10.1073/pnas.0602304104
Balin, B. J., Little, C. S., Hammond, C. J., Appelt, D. M., Whittum-Hudson, J. A.,
Gérard, H. C., et al. (2008). Chlamydophila pneumoniae and the etiology of
late-onset Alzheimer’s disease. J. Alzheimers Dis. 13, 371–380. doi: 10.3233/jad-
2008-13403
Frontiers in Aging Neuroscience | www.frontiersin.org 7 October 2017 | Volume 9 | Article 336
Pritchard et al. Oral Microbiome and Alzheimer’s Disease
Bekris, L. M., Yu, C.-E., Bird, T. D., and Tsuang, D. W. (2010). Genetics
of Alzheimer disease. J. Geriatr. Psychiatry Neurol. 23, 213–227.
doi: 10.1177/0891988710383571
Bian, Z., Brauner, A., Li, Y., and Normark, S. (2000). Expression of and cytokine
activation by Escherichia coli curli fibers in human sepsis. J. Infect. Dis. 181,
602–612. doi: 10.1086/315233
Bielecka, E., Scavenius, C., Kantyka, T., Jusko, M., Mizgalska, D., Szmigielski, B.,
et al. (2014). Peptidyl arginine deiminase from Porphyromonas gingivalis
abolishes anaphylatoxin C5a activity. J. Biol. Chem. 289, 32481–32487.
doi: 10.1074/jbc.C114.617142
Bieler, S., Estrada, L., Lagos, R., Baeza, M., Castilla, J., and Soto, C. (2005). Amyloid
formation modulates the biological activity of a bacterial protein. J. Biol. Chem.
280, 26880–26885. doi: 10.1074/jbc.M502031200
Braak, H., and Braak, E. (1995). Staging of Alzheimer’s disease-related
neurofibrillary changes. Neurobiol. Aging 16, 271–278. doi: 10.1016/0197-
4580(95)00021-6
Brandscheid, C., Schuck, F., Reinhardt, S., Schäfer, K.-H., Pietrzik, C. U.,
Grimm, M., et al. (2017). Altered gut microbiome composition and tryptic
activity of the 5xFADAlzheimer’s mousemodel. J. Alzheimers Dis. 56, 775–788.
doi: 10.3233/JAD-160926
Carrasco, L., Alonso, R., Pisa, D., and Rabano, A. (2017). ‘‘Alzheimer’s disease
and fungal infection,’’ in Handbook of Infection and Alzheimer’s Disease,
ed. J. Miklossy (Amsterdam: IOS Press), 281–294.
Castelijn, G. A. A., van der Veen, S., Zwietering, M. H., Moezelaar, R., and Abee, T.
(2012). Diversity in biofilm formation and production of curli fimbriae and
cellulose of Salmonella Typhimurium strains of different origin in high and low
nutrient medium. Biofouling 28, 51–63. doi: 10.1080/08927014.2011.648927
Chapman, M. R., Robinson, L. S., Pinkner, J. S., Roth, R., Heuser, J., Hammar, M.,
et al. (2002). Role of Escherichia coli curli operons in directing amyloid fiber
formation. Science 295, 851–855. doi: 10.1126/science.1067484
Chen, B.-C., Chen, Y.-H., and Lin, W.-W. (1999). Involvement of p38 mitogen-
activated protein kinase in lipopolysaccharide-induced iNOS and COX-2
expression in J774macrophages. Immunology 97, 124–129. doi: 10.1046/j.1365-
2567.1999.00747.x
Chen, C.-K., Wu, Y.-T., and Chang, Y.-C. (2017). Association between chronic
periodontitis and the risk of Alzheimer’s disease: a retrospective, population-
based, mactched-cohort study.Alzheimers Res. Ther. 9:56. doi: 10.1186/s13195-
017-0282-6
Danborg, P. B., Simonsen, A. H., Waldemar, G., and Heegaard, N. H. (2014). The
potential of microRNAs as biofluid markers of neurodegenerative diseases—a
systematic review. Biomarkers 19, 259–268. doi: 10.3109/1354750X.2014.
904001
Di Benedetto, A., Gigante, I., Colucci, S., and Grano, M. (2013). Periodontal
disease: linking the primary inflammation to bone loss. Clin. Dev. Immunol.
2013:503754. doi: 10.1155/2013/503754
DiCarlo, G., Wilcock, D., Henderson, D., Gordon, M., and Morgan, D. (2001).
Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice.
Neurobiol. Aging 22, 1007–1012. doi: 10.1016/s0197-4580(01)00292-5
Dueholm, M. S., Albertsen, M., Otzen, D., and Nielsen, P. H. (2012). Curli
functional amyloid systems are phylogenetically widespread and display
large diversity in operon and protein structure. PLoS One 7:e51274.
doi: 10.1371/journal.pone.0051274
Dueholm, M. S., Halkjaer, P., Chapman, M., and Otzen, D. (2013). ‘‘Functional
amyloids in bacteria,’’ in Amyloid Fibrils and Prefibrillar Aggregates: Molecular
and Biological Properties, ed. D. E. Otzen (Germany: Wiley), 411–438.
Dueholm, M. S., and Nielsen, P. H. (2017). ‘‘Amyloids—a neglected child of the
slime,’’ inThe Perfect Slime,Microbial Extracellular Polymeric Substances (EPS),
eds H.-C. Flemming, T. R. Neu and J. Wingender (London: IWA Publishing),
113–134.
Dueholm, M. S., Petersen, S. V., Sønderkær, M., Larsen, P., Christiansen, G.,
Hein, K. L., et al. (2010). Functional amyloid in Pseudomonas.Mol. Microbiol.
77, 1009–1020. doi: 10.1111/j.1365-2958.2010.07269.x
Edwards, P. R., and Bruner, D.W. (1938). Two new Salmonella types isolated from
fowls. J. Hyg. 38, 716–720. doi: 10.1017/s0022172400011566
Emery, D. C., Shoemark, D. K., Batstone, T. E., Waterfall, C. M., Coghill, J. A.,
Cerajewska, T. L., et al. (2017). 16S rRNA next generation sequencing analysis
shows bacteria in Alzheimer’s post-mortem brain. Front. Aging Neurosci. 9:195.
doi: 10.3389/fnagi.2017.00195
Epstein, E. A., and Chapman, M. R. (2008). Polymerizing the fibre between
bacteria and host cells: the biogenesis of functional amyloid fibres. Cell.
Microbiol. 10, 1413–1420. doi: 10.1111/j.1462-5822.2008.01148.x
Fan, Y. Y., Cai, Q. L., Gao, Z. Y., Lin, X., Huang, Q., Tang, W., et al. (2017).
APOE ε4 allele elevates the expressions of inflammatory factors and promotes
Alzheimer’s disease progression: a comparative study based on Han and She
populations in the Wenzhou area. Brain Res. Bull. 132, 39–43. doi: 10.1016/j.
brainresbull.2017.04.017
Farkas, I., Takahashi, M., Fukuda, A., Yamamoto, N., Akatsu, H., Baranyi, L.,
et al. (2003). Complement C5a receptor-mediated signaling may be involved
in neurodegeneration in Alzheimer’s disease. J. Immunol. 170, 5764–5771.
doi: 10.4049/jimmunol.170.11.5764
Fischer, O. (1910). Die presbyophrene Demenz, deren anatomische Grundlage
und klinische Abgrenzung. Z. Gesamte Neurol. Psychiatr. 3, 371–471.
doi: 10.1007/bf02893605
Friedland, R. P. (2015). Mechanisms of molecular mimicry involving
the microbiota in neurodegeneration. J. Alzheimers Dis. 45, 349–362.
doi: 10.3233/JAD-142841
Gabay, C., and Kushner, I. (1999). Acute-phase proteins and other
systemic responses to inflammation. N. Engl. J. Med 340, 448–454.
doi: 10.1056/nejm199904293401723
Garcia, M., Lipke, P., and Klotz, S. (2013). Pathogenic microbial amyloids: their
function and the host response. OAMicrobiol. 1:2.
Gatz, M., Mortimer, J. A., Fratiglioni, L., Johansson, B., Berg, S., Reynolds, C. A.,
et al. (2006). Potentially modifiable risk factors for dementia in identical twins.
Alzheimers Dement. 2, 110–117. doi: 10.1016/j.jalz.2006.01.002
Gaugler, J., James, B., Johnson, T., Scholz, K., and Weuve, J. (2016). Alzheimer’s
association report; Alzheimer’s disease facts and figures. Alzheimers Dement.
12, 459–509. doi: 10.1016/j.jalz.2016.03.001
Gophna, U., Barlev, M., Seijffers, R., Oelschlager, T. A., Hacker, J., and Ron, E. Z.
(2001). Curli fibers mediate internalization of Escherichia coli by eukaryotic
cells. Infect. Immun. 69, 2659–2665. doi: 10.1128/iai.69.4.2659-2665.2001
Hajishengallis, G., and Lamont, R. J. (2014). Breaking bad: manipulation of the
host response by Porphyromonas gingivalis. Eur. J. Immunol. 44, 328–338.
doi: 10.1002/eji.201344202
Hajishengallis, G., and Lamont, R. J. (2016). Dancing with the stars: how
choreographed bacterial interactions dictate nososymbiocity and give rise to
keystone pathogens, accessory pathogens and pathobionts. Trends Microbiol.
24, 477–489. doi: 10.1016/j.tim.2016.02.010
Halliday, M. R., Rege, S. V., Ma, Q., Zhao, Z., Miller, C. A., Winkler, E. A., et al.
(2016). Accelerated pericyte degeneration and blood-brain barrier breakdown
in apolipoprotein E4 carriers with Alzheimer’s disease. J. Cereb. Blood Flow
Metab. 36, 216–227. doi: 10.1038/jcbfm.2015.44
Harding, A., Robinson, S., Crean, S., and Singhrao, S. K. (2017). Can better
management of periodontal disease delay the onset and progression of
Alzheimer’s disease? J. Alzheimers Dis. 58, 337–348. doi: 10.3233/JAD-170046
Harris, S. A., and Harris, E. A. (2017). ‘‘Herpes simplex virus type I and
other pathogens are key causative factors in sporadic Alzheimer’s disease,’’ in
Handbook of Infection and Alzheimer’s Disease, ed. J. Miklossy (Amsterdam:
IOS Press), 241–278.
Hartman, K., Brender, J. R., Monde, K., Ono, A., Evans, M. L., Popovych, N.,
et al. (2013). Bacterial curli protein promotes the conversion of PAP248–286 into
the amyloid SEVI: cross-seeding of dissimilar amyloid sequences. PeerJ. 1:e5.
doi: 10.7717/peerj.5
Heintz, C., and Mair, W. (2014). You are what you host: microbiome modulation
of the aging process. Cell 156, 408–411. doi: 10.1016/j.cell.2014.01.025
Herber-Jonat, S., Mittal, R., Gsinn, S., Bohnenkamp,H., Guenzi, E., and Schulze, A.
(2011). Comparison of lung accumulation of cationic liposomes in normal
rats and LPS-treated rats. Inflamm. Res. 60, 245–253. doi: 10.1007/s00011-010-
0260-y
Hill, J. M., Clement, C., Pogue, A. I., Bhattacharjee, S., Zhao, Y., and Lukiw, W. J.
(2014). Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD).
Front. Aging Neurosci. 6:127. doi: 10.3389/fnagi.2014.00127
Hintermann, E., Haake, S. K., Christen, U., Sharabi, A., and Quaranta, V.
(2002). Discrete proteolysis of focal contact and adherens junction components
in Porphyromonas gingivalis-infected oral keratinocytes: a strategy for
cell adhesion and migration disabling. Infect. Immun. 70, 5846–5856.
doi: 10.1128/iai.70.10.5846-5856.2002
Frontiers in Aging Neuroscience | www.frontiersin.org 8 October 2017 | Volume 9 | Article 336
Pritchard et al. Oral Microbiome and Alzheimer’s Disease
Huang, H., Rose, J. L., and Hoyt, D. G. (2004). p38 mitogen-activated protein
kinase mediates synergistic induction of inducible nitric-oxide synthase
by lipopolysaccharide and interferon-γ through signal transducer and
activator of transcription 1 Ser727 phosphorylation in murine aortic
endothelial cells. Mol. Pharmacol. 66, 302–311. doi: 10.1124/mol.66.
2.302
Itzhaki, R. F. (2016). ‘‘Herpes and Alzheimer’s disease: subversion in the central
nervous system and how it might be halted,’’ in Handbook of Infection and
Alzheimer’s Disease, ed. J. Miklossy (Amsterdam: IOS Press), 67–78.
Itzhaki, R. F., Lathe, R., Balin, B. J., Ball, M. J., Bearer, E. L., Braak, H., et al.
(2016). Microbes and Alzheimer’s disease. J. Alzheimers Dis. 51, 979–984.
doi: 10.3233/JAD-160152
Jayadev, S., Case, A., Alajajian, B., Eastman, A. J., Möller, T., and Garden, G. A.
(2013). Presenilin 2 influences miR146 level and activity in microglia.
J. Neurochem. 127, 592–599. doi: 10.1111/jnc.12400
Jiang, C., Li, G., Huang, P., Liu, Z., and Zhao, B. (2017). The gut microbiota and
Alzheimer’s disease. J. Alzheimers Dis. 58, 1–15. doi: 10.3233/JAD-161141
Kamer, A. R., Craig, R. G., Pirraglia, E., Dasanayake, A. P., Norman, R. G.,
Boylan, R., et al. (2009). TNF-α and antibodies to periodontal bacteria
discriminate between Alzheimer’s disease patients and normal subjects.
J. Neuroimmunol. 216, 92–97. doi: 10.1016/j.jneuroim.2009.08.013
Katz, J., Sambandam, V., Wu, J. H., Michalek, S. M., and Balkovetz, D. F.
(2000). Characterization of Porphyromonas gingivalis-induced degradation
of epithelial cell junctional complexes. Infect. Immun. 68, 1441–1449.
doi: 10.1128/iai.68.3.1441-1449.2000
Klotz, S. A., Sobonya, R. E., Lipke, P. N., and Garcia-Sherman, M. C. (2016).
Serum amyloid P component and systemic fungal infection: does it protect
the host or is it a Trojan Horse? Open Forum Infect. Dis. 3:ofw166.
doi: 10.1093/ofid/ofw166
Kumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S.,
Ghofrani, J., et al. (2016). Amyloid-β peptide protects against microbial
infection in mouse and worm models of Alzheimer’s disease. Sci. Transl. Med.
8:340ra72. doi: 10.1126/scitranslmed.aaf1059
Larsen, P., Nielsen, J. L., Dueholm, M. S., Wetzel, R., Otzen, D., and Nielsen, P. H.
(2007). Amyloid adhesins are abundant in natural biofilms. Environ. Microbiol.
9, 3077–3090. doi: 10.1111/j.1462-2920.2007.01418.x
Larsen, P., Nielsen, J. L., Otzen, D., and Nielsen, P. H. (2008). Amyloid-like
adhesins produced by floc-forming and filamentous bacteria in activated
sludge. Appl. Environ. Microbiol. 74, 1517–1526. doi: 10.1128/AEM.02274-07
Lee, D. C., Rizer, J., Selenica, M. B., Reid, P., Kraft, C., Johnson, A., et al.
(2010). LPS- induced inflammation exacerbates phospho-tau pathology in
rTg4510 mice. J. Neuroinflammation 7:56. doi: 10.1186/1742-2094-7-56
Leira, Y., Domínguez, C., Seoane, J., Seoane-Romero, J., Pías-Peleteiro, J. M.,
Takkouche, B., et al. (2017). Is periodontal disease associated with Alzheimer’s
disease? A systematic review with meta-analysis. Neuroepidemiology 48, 21–31.
doi: 10.1159/000458411
Li, X., Kolltveit, K. M., Tronstad, L., and Olsen, I. (2000). Systemic diseases caused
by oral infection. Clin. Microbiol. Rev. 13, 5476–5558. doi: 10.1128/cmr.13.4.
547-558.2000
Loesche,W. J., and Lopatin, D. E. (1998). Interactions between periodontal disease,
medical diseases and immunity in the older individual. Periodontol. 2000 16,
80–105. doi: 10.1111/j.1600-0757.1998.tb00117.x
Lukiw, W. J. (2013). Variability in miRNA abundance, speciation and complexity
amongst different human populations and potential relevance to AD. Front.
Cell. Neurosci. 7:133. doi: 10.3389/fncel.2013.00133
Lukiw, W. J. (2016). Bacteroides fragilis lipopolysaccharide and inflammatory
signaling in Alzheimer’s disease. Front. Microbiol. 7:1544. doi: 10.3389/fmicb.
2016.01544
Luo, J., Wu, B., Zhao, Q., Guo, Q., Meng, H., Yu, L., et al. (2015). Association
between tooth loss and cognitive function among 3063 Chinese older adults:
a community-based study. PLoS One 10:e0120986. doi: 10.1371/journal.pone.
0120986
MacDonald, A. B., and Miranda, J. M. (1987). Concurrent neocortical borreliosis
and Alzheimer’s disease. Hum. Pathol. 18, 759–761. doi: 10.1016/s0046-
8177(87)80252-6
Maher, B. A., Ahmed, I. A., Karloukovski, V., MacLaren, D. A., Foulds, P. G.,
Allsop, D., et al. (2016). Magnetite pollution nanoparticles in the human brain.
Proc. Natl. Acad. Sci. U S A 113, 10797–10801. doi: 10.1073/pnas.1605941113
Maheshwari, P., and Eslick, G. D. (2017). ‘‘Bacterial infection increases the risk of
Alzheimer’s disease: an evidence-based assessment,’’ in Handbook of Infection
and Alzheimer’s Disease, ed. J. Miklossy (Amsterdam: IOS Press), 151–160.
Marsh, S. E., Abud, E. M., Lakatos, A., Karimzadeh, A., Yeung, S. T., Davtyan, H.,
et al. (2016). The adaptive immune system restrains Alzheimer’s disease
pathogenesis by modulating microglial function. Proc. Natl. Acad. Sci. U S A
113, E1316–E1325. doi: 10.1073/pnas.1525466113
Mawanda, F., and Wallace, R. (2013). Can infections cause Alzheimer’s disease?
Epidemiol. Rev. 35, 161–180. doi: 10.1093/epirev/mxs007
McGeer, P. L., Rogers, J., and McGeer, E. G. (2017). ‘‘Inflammation,
anti-inflammatory agents and Alzheimer’s disease: the last 22 years,’’ in
Handbook of Infection and Alzheimer’s Disease, ed. J. Miklossy (Amsterdam:
IOS Press), 11–15.
Miklossy, J. (1993). Alzheimer’s disease—spirochetosis? Neuroreport 4, 841–848.
doi: 10.1097/00001756-199307000-00002
Miklossy, J. (2011). Alzheimer’s disease—a neurospirochetosis. Analysis of the
evidence following Koch’s and Hill’s criteria. J. Neuroinflammation 8:90.
doi: 10.1186/1742-2094-8-90
Miklossy, J. (2016). Bacterial amyloid and DNA are important constituents
of senile plaques: further evidence of the spirochetal and biofilm nature
of senile plaques. J. Alzheimers Dis. 53, 1459–1473. doi: 10.3233/JAD-
160451
Miklossy, J., Khalili, K., Gern, L., Ericson, R. L., Darekar, P., Bolle, L., et al. (2017).
‘‘Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis
and may be associated with Alzheimer diasease,’’ in Handbook of Infection and
Alzheimer’s Disease, ed. J. Miklossy (Amsterdam: IOS Press), 67–78.
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P.,
Zhao, Z., et al. (2015). Blood-brain barrier breakdown in the aging human
hippocampus. Neuron 85, 296–302. doi: 10.1016/j.neuron.2014.12.032
Mueller-Steiner, S., Zhou, Y., Arai, H., Roberson, E. D., Sun, B., Chen, J.,
et al. (2006). Antiamyloidogenic and neuroprotective functions of cathepsin
B: implications for Alzheimer’s disease. Neuron 51, 703–714. doi: 10.1016/j.
neuron.2006.07.027
Norden, D. M., and Godbout, J. P. (2013). Review: microglia of the aged
brain: primed to be activated and resistant to regulation. Neuropathol. Appl.
Neurobiol. 39, 19–34. doi: 10.1111/j.1365-2990.2012.01306.x
Oli, M. W., Otoo, H. N., Crowley, P. J., Heim, K. P., Nascimento, M. M.,
Ramsook, C. B., et al. (2012). Functional amyloid formation by Streptococcus
mutans.Microbiology 158, 2903–2916. doi: 10.1099/mic.0.060855-0
Olsen, I., and Singhrao, S. K. (2015). Can oral infection be a risk factor for
Alzheimer’s disease? J. Oral Microbiol. 7:29143. doi: 10.3402/jom.v7.29143
Olsen, I., Taubman, M. A., and Singhrao, S. K. (2016). Porphyromonas gingivalis
suppresses adaptive immunity in periodontitis, atherosclerosis and Alzheimer’s
disease. J. Oral Microbiol. 8:33029. doi: 10.3402/jom.v8.33029
Paganini-Hill, A.,White, S. C., and Atchison, K. A. (2012). Dentition, dental health
habits, and dementia: the Leisure World Cohort study. J. Am. Geriatr. Soc. 60,
1556–1563. doi: 10.1111/j.1532-5415.2012.04064.x
Pérez-Cerdá, F., Sánchez-Gómez, M. V., and Matute, C. (2016). The link of
inflammation and neurodegeneration in progressive multiple sclerosis. Mult.
Scler. Demyelinat. Disord. 1:9. doi: 10.1186/s40893-016-0012-0
Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F.,
and Battino, M. (2016). Role of gut microbiota and nutrients in amyloid
formation and pathogenesis of Alzheimer disease. Nutr. Rev. 74, 624–634.
doi: 10.1093/nutrit/nuw023
Poole, S., Singhrao, S. K., Kesavalu, L., Curtis, M. A., and Crean, S. (2013).
Determining the presence of periodontopathic virulence factors in short-term
post-mortem Alzheimer’s disease brain tissue. J. Alzheimers Dis. 36, 665–677.
doi: 10.3233/JAD-121918
Prince, M., Knapp, M., Guerchet, M., McCrane, P., Prina, M., Comas-
Herrera, A., et al. (2014).Dementia UK: Update. 2nd Edn. London: Alzheimer’s
Society.
Ramsook, C. B., Tan, C., Garcia, M. C., Fung, R., Soybelman, G., Henry, R.,
et al. (2010). Yeast cell adhesion molecules have functional amyloid-forming
sequences. Eukaryot. Cell 9, 393–404. doi: 10.1128/EC.00068-09
Riviere, G. R., Riviere, K., and Smith, K. (2002). Molecular and immunological
evidence of oral Treponema in the human brain and their association with
Alzheimer’s disease. Oral Microbiol. Immunol. 17, 113–118. doi: 10.1046/j.
0902-0055.2001.00100.x
Frontiers in Aging Neuroscience | www.frontiersin.org 9 October 2017 | Volume 9 | Article 336
Pritchard et al. Oral Microbiome and Alzheimer’s Disease
Rokad, F., Moseley, R., Hardy, S. R., Chukkapalli, S., Crean, S., Kesavalu, L.,
et al. (2017). Cerebral oxidative stress and microvasculature defects in TNF-α
expressing transgenic and Porphyromonas gingivalis-infected ApoE−/− mice.
J. Alzheimers Dis. 60, 359–369. doi: 10.3233/jad-170304
Romero, D., Aguilar, C., Losick, R., and Kolter, R. (2010). Amyloid fibers provide
structural integrity to Bacillus subtilis biofilms. Proc. Natl. Acad. Sci. U S A 107,
2230–2234. doi: 10.1073/pnas.0910560107
Romero, D., Vlamakis, H., Losick, R., and Kolter, R. (2011). An accessory protein
required for anchoring and assembly of amyloid fibres in B. subtilis biofilms.
Mol. Microbiol. 80, 1155–1168. doi: 10.1111/j.1365-2958.2011.07653.x
Romero, D., Vlamakis, H., Losick, R., and Kolter, R. (2014). Functional analysis
of the accessory protein TapA in Bacillus subtilis amyloid fiber assembly.
J. Bacteriol. 196, 1505–1513. doi: 10.1128/JB.01363-13
Scully, C., and Felix, D. H. (2005). Oral medicine—update for the dental
practitioner. Red and pigmented lesions. Br. Dent. J. 199, 639–645.
doi: 10.1038/sj.bdj.4813017
Shahnawaz, M., and Soto, C. (2012). Microcin amyloid fibrils A are reservoir of
toxic oligomeric species. J. Biol. Chem. 287, 11665–11676. doi: 10.1074/jbc.
M111.282533
Sheets, S. M., Potempa, J., Travis, J., Casiano, C. A., and Fletcher, H. M. (2005).
Gingipains from Porphyromonas gingivalisW83 induce cell adhesionmolecule
cleavage and apoptosis in endothelial cells. Infect. Immun. 73, 1543–1552.
doi: 10.1128/iai.73.3.1543-1552.2005
Sheng, J. G., Bora, S. H., Xu, G., Borchelt, D. R., Price, D. L., and
Koliatsos, V. E. (2003). Lipopolysaccharide-induced-neuroinflammation
increases intracellular accumulation of amyloid precursor protein and
amyloid β peptide in APPswe transgenic mice. Neurobiol. Dis. 14, 133–145.
doi: 10.1016/s0969-9961(03)00069-x
Singhrao, S. K., Chukkapalli, S., Poole, S., Velsko, I., Crean, S., and Kesavalu, L.
(2017). Chronic Porphyromonas gingivalis infection accelerates the occurrence
of age-related granules in ApoE−/− mice. J. Oral Microbiol. 9:1270602.
doi: 10.1080/20002297.2016.1270602
Singhrao, S. K., Harding, A., Chukkapalli, S., Olsen, I., Kesavalu, L., and Crean, S.
(2016). Apolipoprotein E related co-morbidities and Alzheimer’s disease.
J. Alzheimers Dis. 51, 935–948. doi: 10.3233/JAD150690
Singhrao, S. K., Harding, A., Poole, S., Kesavalu, L., and Crean, S. (2015).
Porphyromonas gingivalis: periodontal infection and its putative
links with Alzheimer’s disease. Mediators Inflamm. 2015:137357.
doi: 10.1155/2015/137357
Solomon, E. B., Niemira, B. A., Sapers, G. M., and Annous, B. A. (2005).
Biofilm formation, cellulose production, and curli biosynthesis by Salmonella
originating from produce, animal, and clinical sources. J. Food Prot. 68,
906–912. doi: 10.4315/0362-028x-68.5.906
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B.,
et al. (2010). The Alzheimer’s disease-associated amyloid β-protein is an
antimicrobial peptide. PLoS One 5:e9505. doi: 10.1371/journal.pone.0009505
Tamagno, E., Guglielmotto, M., Aragno, M., Borghi, R., Autelli, R., Giliberto, L.,
et al. (2008). Oxidative stress activates a positive feedback between the γ- and
β-secretase cleavages of the β-amyloid precursor protein. J. Neurochem. 104,
683–695. doi: 10.1111/j.1471-4159.2007.05072.x
Tarkowski, E., Blennow, K., Wallin, A., and Tarkowski, A. (1999). Intracerebral
production of tumor necrosis factor-α, a local neuroprotective agent, in
Alzheimer disease and vascular dementia. J. Clin. Immunol. 19, 223–230.
doi: 10.1023/A:1020568013953
Underwood, D. C., Osborn, R. R., Bochnowicz, S., Webb, E. F., Rieman, D. J.,
Lee, J. C., et al. (2000). SB 239063, a p38 MAPK inhibitor, reduces neutrophilia,
inflammatory cytokines, MMP-9, and fibrosis in lung.Am. J. Physiol. Lung Cell.
Mol. Physiol. 279, L895–L902.
Wu, Z., Ni, J., Liu, Y., Teeling, J. L., Takayama, F., Collcutt, A., et al.
(2017). Cathepsin B plays a critical role in inducing Alzheimer’s disease-like
phenotypes following chronic systemic exposure to lipopolysaccharide from
Porphyromonas gingivalis in mice. Brain Behav. Immun. 65, 350–361.
doi: 10.1016/j.bbi.2017.06.002
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M.,
Contreras, M., et al. (2012). Human gut microbiome viewed across age and
geography. Nature 486, 222–227. doi: 10.1038/nature11053
Zhan, X., Stamova, B., Jin, L. W., DeCarli, C., Phinney, B., and Sharp, F. R.
(2016). Gram-negative bacterial molecules associate with Alzheimer
disease pathology. Neurology 87, 2324–2332. doi: 10.1212/WNL.0000000000
003391
Zhao, Y., Jaber, V., and Lukiw, W. J. (2017). Secretory products of the human
GI tract microbiome and their potential impact on Alzheimer’s disease (AD):
detection of lipopolysaccharide (LPS) in AD hippocampus. Front. Cell. Infect.
Microbiol. 7:318. doi: 10.3389/fcimb.2017.00318
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Pritchard, Crean, Olsen and Singhrao. This is an open-access
article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Aging Neuroscience | www.frontiersin.org 10 October 2017 | Volume 9 | Article 336
